Wellgistics Health, Inc. (WGRX)

NCM – Цена в реальном времени. Валюта: USD

0.08

-0.01 (-14.44%)

При закрытии: May 12, 2026, 4:00 PM EDT

14.04.2026

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Wellgistics Health Inc. (NASDAQ: WGRX) resulting from allegations that Wellgistics may have issued materially misleading business information to the investing public. So what: If you purchased Wellgistics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee.

14.04.2026

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization Combined ecosystem provides potential reach to an estimated 200,000+ patient lives across pharmaceutical and provider networks TAMPA, FL / ACCESS Newswire / April 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs. The execution of the joint venture formalizes the previously announced non-binding letter of intent and represents a significant milestone in aligning both organizations' technology platforms and operational teams into a unified ecosystem designed to accelerate patient access and improve the efficiency of pharmaceutical commercialization.

13.04.2026

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

10.04.2026

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Wellgistics Health is a healthcare technology and pharmaceutical logistics company.

23.03.2026

Why Are Shares Of Wellgistics Health Falling?

Despite the positive news, investors are concerned that the acquisition may not be enough to turn around the negative revenue growth Wellgistics experienced in the last year. Revenue fell about half between the last two quarters, going from $7 million to $3 million.

23.03.2026

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization. The proposed all stock transaction, if completed, is intended to enhance Wellgistics' existing revenue-generating healthcare platform by expanding capabilities adjacent to its core technology-enabled pharmacy distribution and services business.

19.03.2026

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

TAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ , today announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company's Board of Directors, entered into agreements with the Company to convert an aggregate of approximately $2.0 million of accrued compensation into shares of the Company's common stock at a conversion price of $0.20 per share, representing a premium to the Company's recent trading price. In connection with the conversion, the Company will issue approximately 10,000,000 shares of common stock.

Видео

No Data

There is no data to display

Пресс-релизы

14.04.2026

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

14.04.2026

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

13.04.2026

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

23.03.2026

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Health, Inc. (WGRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Wellgistics Health, Inc. (WGRX)

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Why Are Shares Of Wellgistics Health Falling?

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Видео

No Data

Пресс-релизы

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Why Are Shares Of Wellgistics Health Falling?

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Видео

No Data

Пресс-релизы

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Search stocks

Wellgistics Health, Inc. (WGRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Wellgistics Health, Inc. (WGRX)

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Why Are Shares Of Wellgistics Health Falling?

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Видео

No Data

Пресс-релизы

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Why Are Shares Of Wellgistics Health Falling?

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Видео

No Data

Пресс-релизы

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders